STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model

被引:18
作者
Gao Lei [1 ]
Chen Li [1 ]
Fei Xin-hong [1 ]
Qiu Hui-ying [1 ]
Hong, Zhou [1 ]
Jian-min, Wang [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
关键词
K562; cells; leukemia; multidrug-resistance; imatinib mesylate; xenograft model antitumor assays;
D O I
10.1097/00029330-200606010-00006
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background The development of the targeted signal transduction inhibitor STI571 has prompted us to treat chronic myeloid leukemia in different ways. Since STI571 may reverse multidrug-resistance of K562/MDR cells in vitro, we studied the effect of STI571 on multidrug-resistant K562 cells in vivo. Methods Multidrug-resistant human leukemia cell line K562-n/VCR expresses both bcr/abl fusion gene and multi-drug resistance (mdr1) gene. It is a vincristine resistant cell line subcloned from the vincristine (VCR) sensitive cell line K562-n induced by vincristine in vitro. K562-n and K562-n/VCR cells were inoculated subcutaneously into both sides of nude mice breast (5 x 10(6) cells/each) to establish a human leukemia xenograft model. The incidence and volume of tumor were observed. In the tumor-bearing nude mice, anti-tumor drugs vincristine, daunorubicin (DNR), STI571, and STI571 plus VCR for the treatment of mdr1 and bcr/abl double positive leukemia were studied respectively. Results The tumor incidence was 100% in the nude mice inoculated with either K562-n or K562-n/VCR. The transcription of the mdr1 gene and expression of P-gp were negative in K562-n cells but positive in K562-n/VCR cells. The intracellular accumulation of DNR in K562-n cells was higher than that in K562-n/VCR cells (P < 0.05). The tumor incidence of K562-n/VCR cells in nude mice was much higher than that of K562-n cells in chemotherapy groups, and the mean volume of the tumors was also larger (P < 0.05). STI571 combined with VCR significantly suppressed the proliferation of K562-n/VCR cells. Conclusions The MDR characteristics of K562-n/VCR in vivo were the same as in vitro. STI571 had a significant tumor-suppressing effect on VCR-sensitive leukemia cells and a moderate effect on MDR leukemia cells. VCR combined with STI571 had an excellent tumor-suppressing effect on both K562-n/VCR and K562-n in the human-nude mice xenograft model.
引用
收藏
页码:911 / 918
页数:8
相关论文
共 23 条
[1]
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 [J].
Baer, MR ;
George, SL ;
Dodge, RK ;
O'Loughlin, KL ;
Minderman, H ;
Caligiuri, MA ;
Anastasi, J ;
Powell, BL ;
Kolitz, JE ;
Schiffer, CA ;
Bloomfield, CD ;
Larson, RA .
BLOOD, 2002, 100 (04) :1224-1232
[2]
[陈莉 Chen Li], 2004, [第二军医大学学报, Academic Journal of Second Military Medical University], V25, P507
[3]
CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs [J].
Fang, GF ;
Kim, CN ;
Perkins, CL ;
Ramadevi, N ;
Winton, E ;
Wittmann, S ;
Bhalla, KN .
BLOOD, 2000, 96 (06) :2246-2253
[4]
BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[5]
MAMMALIAN MULTIDRUG RESISTANCE GENE - COMPLETE CDNA SEQUENCE INDICATES STRONG HOMOLOGY TO BACTERIAL TRANSPORT PROTEINS [J].
GROS, P ;
CROOP, J ;
HOUSMAN, D .
CELL, 1986, 47 (03) :371-380
[6]
LIANG YJ, 2000, CHINESE PHARMACOL B, V16, P705
[7]
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies [J].
Mahadevan, D ;
List, AF .
BLOOD, 2004, 104 (07) :1940-1951
[8]
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571:: diverse mechanisms of resistance [J].
Mahon, FX ;
Deininger, MWN ;
Schultheis, B ;
Chabrol, J ;
Reiffers, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 2000, 96 (03) :1070-1079
[9]
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models [J].
Mahon, FX ;
Belloc, F ;
Lagarde, V ;
Chollet, C ;
Moreau-Gaudry, F ;
Reiffers, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 2003, 101 (06) :2368-2373
[10]
THE MTT CELL VIABILITY ASSAY FOR CYTOTOXICITY TESTING IN MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELLS [J].
MARKS, DC ;
BELOV, L ;
DAVEY, MW ;
DAVEY, RA ;
KIDMAN, AD .
LEUKEMIA RESEARCH, 1992, 16 (12) :1165-1173